$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Simplified HPLC Method for the Determination of Prazosin in Human Plasma and Its Application to Single-dose Pharmacokinetics 원문보기

The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology, v.13 no.2, 2005년, pp.90 - 94  

Gwak, Hye-Sun (College of Pharmacy, Ewha Womans University) ,  Chun, In-Koo (College of Pharmacy, Dongduk Women's University)

Abstract AI-Helper 아이콘AI-Helper

Prazosin hydrochloride is an antihypertensive drug with selective ${\alpha}_1$-adrenoreceptor blocking effects. A simple high performance liquid chromatographic method has been developed and validated for the quantitative determination of prazosin in human plasma. A reversed-phase C18 c...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

제안 방법

  • Intra-day accuracy and precision of the method were estimated by assaying five replicate plasma samples at five different concentrations, in five analytical runs. The overall mean precision was defined by the percentage of relative standard deviation (RSD) of five standards at five different concentrations analyzed on the same day.
  • Seven calibration samples (0.5, 1, 5, 10, 20, 30 and 50 ng/ ml) were prepared by spiking blank plasma with appropriate volumes of the working solutions. Quality control samples (0.

대상 데이터

  • The assay was applied to a pharmacokinetic study of prazosin following 2-mg single dose. According to the Guidance for Bioequivalence Test of Korea Food and Drug Administration, eight male and eight female healthy volunteers aged between 19 and 25 years were selected for the study. All subjects gave their written informed consents, and the clinical protocol was approved by the Ethics and Review Committee.
  • The mobile phase was degassed before use. The fluorescence detector was set at excitation and emission wavelengths of 250 and 370 nm, respectively. All analyses were performed at room temperature.

데이터처리

  • 5 - 50 ng/ml, including the LOQ. Linearity was assessed by a weighted least squares regression coefficient. Calibration curve was found to have a correlation coefficient (r2) of 1, slope of 0.
본문요약 정보가 도움이 되었나요?

참고문헌 (13)

  1. Akduman, B. and Crawford, E. D. (2001). Terazosin, doxazosin and prazosin: current clinical experience. Urology 58, 49-54 

  2. Cheah, P. Y., Yuen, K. H. and Liong, M. L. (2000). Improved high-performance liquid chromatographic analysis of terazosin in human plasma. J Chromatogr. B. Biomed. Sci. Appl. 745, 439-443 

  3. Cho, E. S., Kang, S. H. and Chun, I. K. (2002). Determination of terazosin in human plasma by liquid chromatography and bioequivalence study of teratonin tablets. J Kor. Pharm. Sci. 32, 119-125 

  4. Constantine, J. W. (1975). Analysis of the hypotensive actions of prazosin. Postgrad. Med. Spec No, 18-35 

  5. Food and Drug Administration, Guidance for Industry: Bioanalytical method validation, Center for Drug Evaluation and Research, Rockville, MD, 2001 

  6. Hess, H. J. (1975). Prazosin: biochemistry and structure-activity studies with prazosin. Postgrad. Med. Spec No, 9-17 

  7. Hobbes, D. C., Twomey, T. M. and Palmer, R. F. (1978). Pharmacokinetics of prazosin in man. J Clin. Pharmacal. 18, 402-406 

  8. Kamas, H. T., Shiu, G. and Shah, V. P. (1991). Validation of bioanalytical methods. Pharm. Res. 8, 421-426 

  9. Kang, B. C., Yang, C. Q., Rhee, J. E., Suh, O. K. and Shin, W. G. (2001). High-performance liquid chromatographic analysis and pharmacokinetics of terazosin in healthy volunteers. Res. Cammun. Mal. Pathal. Pharmacal. 110, 371-377 

  10. Patterson, S. E. (1985). Terazosin kinetics after oral and intravenous doses. Clin. Pharmacal. Ther. 38, 423-427 

  11. Rathinavelu, A. and Malave, A. (1995). High-performance liquid chromatography using electrochemical detection for the determination of prazosin in biological samples. J Chromatogr. B. Biomed. Sci. Appl. 670, 177-182 

  12. Sekhar, B. C., Rao, T. R., Sekhar, K. R., Naidu, M. U., Shobha, J. C., Rani, P. U., Kumar, T. V. and Kumar, V. P. (1998). Determination of terazosin in human plasma, using high-performance liquid chromatography with fluorescence detection. J Chromatogr. B. Biomed. Sci. Appl. 710, 137-142 

  13. Vincent, J., Meredith, P. A., Reid, J. L., Elliott, H. L. and Rubin, P. C. (1985). Clinical pharmacokinetics of prazosin. Clin. Pharmacokinet. 10. 144-154 

저자의 다른 논문 :

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로